← Open Payments lookup

VANIA LORVANIS: Open Payments

NPI 1386259018 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$456 in 20 payments from 12 companies in 2025. Trend: 2023 $215 · 2024 $1,303 · 2025 $456

Food & beverage: $456
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation7$140
Madrigal Pharmaceuticals1$108
Novo Nordisk Inc2$35
AstraZeneca Pharmaceuticals LP2$32
GlaxoSmithKline, LLC.1$22
Exact Sciences Corporation1$20
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Otsuka America Pharmaceutical, Inc.1$18
Lilly USA, LLC1$17
Corcept Therapeutics1$17

Products named: REZDIFFRA, LEQVIO, ENTRESTO, Ozempic, TRELEGY ELLIPTA, Cologuard Collection Kit, XIFAXAN, REXULTI.

Industry payments across NY — which companies pay providers there.